Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 4, 1996, Pages 415-416

  Ilan, Y ^a   Shouval, D ^a   Galun, E ^a   Goldin, E ^a   Ligumsky, M ^a   Friedman, G ^a   Kaspa, R Tur ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Barrett's esophagus; Inflammatory bowel disease; Liver transplantation; Malignancy

Indexed keywords

AZATHIOPRINE; CISAPRIDE; CYCLOSPORIN; OMEPRAZOLE; PREDNISONE;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CASE REPORT; DISEASE PREDISPOSITION; ENDOSCOPY; ESOPHAGUS CARCINOMA; FATALITY; FEMALE; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029969502     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609006420     Document Type: Article

References (18)

1. Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993;25:1397-9.
2. Poison RJ, Neuberger J, Forman D, Calne R, Williams R. De novo malignancies after liver transplantation. Transplant Proc 1988;20:94-7.
3. Mühlbacher F, Piza F. Orthotopic liver transplantation for secondary malignancies of the liver. Transplant Proc 1987; 19:2396-8.
4. Cherqui D, Duvoux C, Plassa F, Gaulard P, Julein M, Fagniez P-L, et al. Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 1993;56:1023-6.
5. Bleday R, Lee E, Jessurun J, Heine J, Wong D. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36:908-12.
6. Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakisoe S, Starzl TE. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990;11:477-80.
7. Casavilla A, Moysiuk Y. Esophageal complications in orthotopic liver transplant patients. Transplantation 1991;52:150-1.
8. Vickers CR, O'Connor HJ, Quintero GA, Aerts RJ, Elias E, Neuherger JM. Delayed perforation of the esophagus after variceal sclerotherapy and hepatic transplantation. Gastrointest Endosc 1989;35:459.
9. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology 1984;87:927-33.
10. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lines (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
11. Sartori S, Nielsen I, Trevisani L, Pazzi P, Malacarne P. Barrett's esophagus after antineoplastic chemotherapy. Endoscopy 1990; 22:152.
12. Sartori S, Nielsen I, Indelli M, Trevisani L, Pazzi P, Grandi E. Barrett esophagus after chemotherapy with chyclophosphamide. methotrexate and 5-fluorouacil (CMF): an iatrogenic injury? Ann Intern Med 1991;114:210-1.
13. Peters FTM, Sleijfer DT, van Imhoff GW, Kleibeuker JH. Is chemotherapy associated with development of Barrett's esophagus? Digest Dis Sci 1993;38:923-6.
14. Herrera JL, Uzel C, Mortino E, Cook C. Barret's esophagus: lack of association with adjuvant chemotherapy for localized breast carcinoma. Gastroendosc 1992;38:351-3.
15. Hoover R, Fraumeni JF. Risk of cancer in renal transplant recipients. Lancet 1973;2:55.
16. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31:800-6.
17. Penn I. Cancer is a complication of severe immunosuppression in the prosttransplant period. Surg Gynecol Obstet 1986; 162:603-10.
18. Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration. EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991;23:1473-6.